Clinical Trial Update: Effect of Angiotensin II Receptor Blockers (ARB) on Left Ventricular Reverse Remodelling After Aortic Valve Replacement in Severe Valvular Aortic Stenosis [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating whether angiotensin II receptor blockers improve left ventricular reverse remodeling after aortic valve replacement in severe …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aortic Valve Stenosis
• Atrial Fibrillation
• Left Ventricular Hypertrophy

Drugs mentioned

• Angiotensin II receptor blockers (ARB)

Snippet

Sponsor: Odense University Hospital | Conditions: Aortic Valve Stenosis, Left Ventricular Hypertrophy | Phase 3 | Status: UNKNOWN